Sales and Marketing

Showing 15 posts of 11527 posts found.

Boehringer to make cancer antibody for Apexigen

December 11, 2012 Manufacturing and Production, Sales and Marketing APX005, Apexigen, Boehringer

Boehringer Ingelheim has won a contract from US biotech company Apexigen to manufacture APX005, an antibody-based drug candidate for various …

Pharma applauds government strategy

December 11, 2012 Sales and Marketing ABPI, BIA, Cameron, Willetts

The ABPI and BioIndustry Association (BIA) have both welcomed the government’s update on its Strategy for UK Life Sciences, launched …

Perjeta reduces risk of death

December 11, 2012 Sales and Marketing Cancer, Perjeta, Roche

Roche’s cancer drug Perjeta helps reduce the risk of death by 34% in patients with HER2-positive metastatic breast cancer (mBC), …

Life Healthcare adds three heads to its team

December 11, 2012 Medical Communications, Sales and Marketing Life Healthcare

Comms agency Life Healthcare Communications has added Steve Lewis, Helen Gillingham and Rosie Hider to its creative output.

Growth in GP drug prescriptions

December 11, 2012 Sales and Marketing GPs, NHS, UK, doctors, prescribing

The volume of GP-prescribed drugs grew by an annual average of 8.4% in the years 1995-2010, according to new government …

Alzheimer’s drug lowers mortality

December 7, 2012 Sales and Marketing Alzheimer's, Janssen, Razadyne, Roche, lilly

A study of Janssen Pharmaceuticals’ Razadyne suggests that the Alzheimer’s drug helped patients stay alive longer and slowed their cognitive …

Add value, pharma urged

December 7, 2012 Medical Communications, Sales and Marketing ABPI, CCGs, NHS, Pharmafocus, Prescriber

Pharma will only form lasting relationships with the NHS in future by demonstrating its value, according to Kevin Blakemore, NHS …

Working Life: Caroline Horwood

December 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Working Life

How did you find your way into your current role?Through an exciting and challenging route over 25 years! The key …

Circassia appoints new head to its Board of directors

December 6, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Jean-Jacques Garaud to its Board of directors. Garaud has extensive …

‘Open door’ for pharma

December 6, 2012 Sales and Marketing CCGs, NHS, NICE, Pharmafocus, Prescriber, UK

The NHS’s new clinical commissioning groups (CCGs) will be more welcoming to approaches from pharma than the old PCTs were, …

‘Risk share’ with us, say CCGs

December 6, 2012 Sales and Marketing CCGs, NHS, Pharmafocus, Prescriber, pharma

Pharma companies have been urged to “put your head on the block” by coming up with risk-sharing funding plans for …

uniQure appoints Basilea’s chief commercial officer

December 6, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Basilea, uniQure

Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …

ImmunoCellular appoints Andrew Gengos as chief executive

December 5, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Gengos, ImmunoCellular

Clinical stage firm ImmunoCellular Therapeutics has announced the appointment of Andrew Gengos as president and chief executive and member of …

New boost for drug candidates

December 5, 2012 Research and Development, Sales and Marketing Bayer, EFPIA, K4DD, Leiden

A new project is trying to increase the hit rates of successful drug candidates by improving the way they are …

Trajenta may reduce stroke damage

December 4, 2012 Research and Development, Sales and Marketing Boehringer, EMA, Trajenta, diabetes, linagliptin

Boehringer Ingelheim’s  diabetes drug Trajenta could one day be used to minimise the effects of brain damage following stroke. Scientists …
The Gateway to Local Adoption Series

Latest content